Clinical Features	Time to Death		YEARS_TO_BIRTH		PATHOLOGIC_STAGE		PATHOLOGY_T_STAGE		PATHOLOGY_M_STAGE		GENDER		RADIATION_THERAPY	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
GNAQ	40 (50%)	40	0.042875	0.487	0.46728	1	0.00158	0.0774	0.80145	1	0.051458	0.487	1	1	0.61532	1
GNA11	36 (45%)	44	0.20282	1	0.74948	1	0.059669	0.487	0.8366	1	0.30738	1	0.65284	1	0.082765	0.579
EIF1AX	10 (12%)	70	0.25494	1	0.41917	1	1	1	0.66642	1	1	1	0.3197	1	1	1
SF3B1	18 (22%)	62	0.0071281	0.147	0.23056	1	0.87928	1	0.88075	1	0.57284	1	0.59646	1	0.54489	1
BAP1	22 (28%)	58	0.0090108	0.147	0.11926	0.73	0.43441	1	0.43004	1	0.26549	1	0.45846	1	1	1
CYSLTR2	3 (4%)	77	0.67553	1	0.42477	1	0.68389	1	0.77981	1	1	1	1	1	1	1
SFRS2	3 (4%)	77	0.83165	1	0.70389	1	1	1	0.57802	1	1	1	1	1	1	1